Description: The introduction of new gene and cell treatments is not without scrutiny. Although these treatments are often curative, they come with a significant price tag. Health plan actuaries find themselves wondering if the intended outcome supports the cost and whether the potential medical cost savings will offset the high drug cost. The Institute for Clinical and Economic Review (ICER) reviews results from clinical trials to produce a report evaluating the cost-effectiveness of new therapies. Depending on the results, the ICER report can be used by pharmaceutical companies to justify the high cost or by the health plan to do the opposite. Go beyond the ICER report and discuss an alternative method for valuing new drugs using nonmedical revenue streams, such as disability and nutrition benefits, and return-on-investment modeling. By attending this session, you will have a better understanding of the nonmedical revenue streams, such as disability and nutrition assistance benefits, that may offset the cost of a drug and how those revenue streams can be incorporated into return-on-investment modeling.

Description: Jump into an informative discussion on Behavioral Economics (BE) that will 'nudge' you away from traditional economic thinking. We'll share a primer on key BE concepts and explore ways to actively use these approaches in underwriting applications, marketing and more. Using simple Behavioral Economics (BE) design approaches, carriers can improve applicant disclosure of medical conditions on insurance applications, claims and mortality experience, website effectiveness, and much more.

Description: This is a conversation with two critical staff members of the Society of Actuaries (SOA) about their experience there. Jane Lesch is a non-actuary who has been working at the SOA for over 20 years, and is an engagement specialist. Mike Boot is an actuary who retired at the end of February after 15 years at the SOA, most recently as managing director. We spoke to both Jane and Mike to get their take on what leadership is about, and how working at the SOA impacted them.

Description: Discover the key components of value-based care (VBC) contracts and their impact on provider credibility. Learn about benchmarks, measurement period results, and the unique challenges providers face in managing insurance risk. Gain insights into reducing costs and aligning financial incentives in the US healthcare market.

Description: Explore an essay collection from the Society of Actuaries (SOA) Research Institute that focuses on how climate change may impact retirement security.

Description: Report summarizing the results of the 2018 PBITT UL with Secondary Guarantees Survey

Description: